Compounds > 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Page last updated: 2024-10-21

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Deficiency, Magnesium

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Deficiency, Magnesium in 1 studies

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Muroyama, A1
Inaka, M1
Matsushima, H1
Sugino, H1
Marunaka, Y1
Mitsumoto, Y1

Other Studies

1 other study available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Deficiency, Magnesium

ArticleYear
Enhanced susceptibility to MPTP neurotoxicity in magnesium-deficient C57BL/6N mice.
    Neuroscience research, 2009, Volume: 63, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Causality; Corpus Striatum; Disease Models, A

2009